SAFX vs XRAY · P/E 1.5, $123.6M cap vs rev $1.78B
XCF Global, Inc. Class A Common Stock (SAFX) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
XCF Global, Inc. Class A Common Stock (SAFX) is a utilities - renewable company listed on NASDAQ.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported SAFX revenue for 2025-12-31 was $0. Net income was $74.0M. SAFX currently screens at market cap $123.6M and trailing P/E 1.5.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
SAFX currently screens at market cap $123.6M and trailing P/E 1.5. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the SAFX and XRAY stock pages for the full models.
Not investment advice.